COVID-19 and the Future of Our Health Research and Innovation System
Life Sciences Ontario, in collaboration with Shift Health, is convening an online session, “COVID-19 and the Future of Our Health Research and Innovation System” on May 28 from 3:00 to 4:30 pm EDT. Speakers include: Dr. Jim Tartaglia, Vice-President R&D, Global Head of Projects, Sanofi Pasteur; Connie Côté, CEO, Health Charites Coalition of Canada; CIHR’s Institute of Infection and Immunity; Bogi Eliasen, Director of Health, Copenhagen Institute for Futures Studies; and Dr. Ryan Wiley, President, Shift Health. More details are available here. To read “COVID-19 and the Future of Health Research and Innovation”, a recent report published by Shift Health, please click here.

Members of the CCRA extend their congratulations to Dr. Elizabeth Eisenhauer, OC, MD, FRCPC, FRSC who was recently announced as the recipient of the
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s (LLSC) Operating Grant program for research aimed at preventing, detecting and treating all types of blood cancers. The application process consists of two phases. The first phase is submission and consideration of a Lette...